Saturday, March 19, 2022 10:01:05 PM
The FOURTH Clot Shot, is proof this is NOT WORKING and we need AVIPTADIL AND OR ZYESAMI. ~ posted by Joe Kaplan @ iHub
https://rumble.com/vxeqvu-pathologist-on-ryan-cole-on-the-mystery-blood-clots.html
We need ZYESAMI/AVIPTADIL/RFL-100 now!!
Dear Dr. Califf and Dr. Fauci:
We are writing regarding a recent report of a physician practicing in Texas who has used a treatment—ZYESAMI—under the Right to Try Act to save COVID-19 patients’ lives.[1] Our understanding is the drug manufacturer, NRx Pharmaceuticals, applied for three Emergency Use Authorization’s (EUA) with the Food and Drug Administration (FDA) for ZYESAMI. NRx submitted its most recent EUA application on January 4, 2022 but the FDA has not yet granted this authorization. However, we are told the FDA refuses to review the data until the completion of clinical trials later this year.[2] We write to request information on the FDA’s review of ZYESAMI, as well as other information about treatment options for Americans suffering from COVID-19.
According to the physician, more than 20 patients suffering respiratory failure from COVID-19 received ZYESAMI as authorized under Right to Try.[3] At the end of the letter, we included the stories of three individuals that credit ZYESAMI with saving their lives. It is our understanding the patients received ZYESAMI after prior administration of remdesivir did not improve the patients’ conditions.[4] All the patients were at the very end stage of COVID and were not expected to recover. Upon receiving ZYESAMI, no serious adverse events associated with use were reported and 16 of the 20 patients left the hospital.[5] According to the physician, patients with ARDS normally have a 40 percent mortality rate.[6] With ZYESAMI, the mortality rate decreased to roughly 10 percent.[7]
.
.
.
https://www.wispolitics.com/2022/u-s-sen-johnson-leads-colleagues-in-demanding-answers-from-dr-califf-and-dr-fauci/
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM